Cyclin D1 anticorps (C-Term)

N° du produit ABIN1881175

Cet anticorps Lapin Polyclonal détecte spécifiquement Cyclin D1 dans WB. Il présente une réactivité envers Humain et a été mentionné dans 6+ publications.

Aperçu rapide pour Cyclin D1 anticorps (C-Term) (ABIN1881175)

Antigène: Cyclin D1 (CCND1)

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Cyclin D1 est non-conjugé

Application: Western Blotting (WB)

Clone: RB42158

Détail du produit anti-Cyclin D1 anticorps

Épitope: AA 267-294, C-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This CCND1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 267-294 amino acids from the C-terminal region of human CCND1.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Références pour anticorps anti-Cyclin D1 (ABIN1881175)

Yang, Wei, Wang, Shen, Xu, Cao: "TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway." dans: International journal of clinical and experimental pathology, Vol. 8, Issue 9, pp. 11837-46, (2016) (PubMed).

Aggarwal, Vaites, Kim, Mellert, Gurung, Nakagawa, Herlyn, Hua, Rustgi, McMahon, Diehl: "Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase." dans: Cancer cell, Vol. 18, Issue 4, pp. 329-40, (2010) (PubMed).

Halilovic, She, Ye, Pagliarini, Sellers, Solit, Rosen: "PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling." dans: Cancer research, Vol. 70, Issue 17, pp. 6804-14, (2010) (PubMed).

Zheng, Armes, Slavin, Zhu, Ni: "Preliminary comparison of tumor biologic factors in breast carcinomas from Australian and Chinese women." dans: Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology, Vol. 32, Issue 3, pp. 155-60, (2010) (PubMed).

Satiroglu-Tufan, Dodurga, Gok, Cetinkaya, Feitelson: "RNA interference-mediated URG4 gene silencing diminishes cyclin D1 mRNA expression in HepG2 cells." dans: Genetics and molecular research : GMR, Vol. 9, Issue 3, pp. 1557-67, (2010) (PubMed).

Iwatani, Fujimoto, Ito: "Cyclin D1 blocks the anti-proliferative function of RUNX3 by interfering with RUNX3-p300 interaction." dans: Biochemical and biophysical research communications, Vol. 400, Issue 3, pp. 426-31, (2010) (PubMed).

Détails sur Cyclin D1

Antigène: Cyclin D1 (CCND1)

Autre désignation: CCND1

Sujet: The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis.

Poids moléculaire: 33729

NCBI Accession: NP_444284

UniProt: P24385

Pathways: Signalisation PI3K-Akt, Cycle Cellulaire, Mitotic G1-G1/S Phases, ER-Nucleus Signaling